Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT02536820

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Fundación Salutia (from the registry)
Registry
  • NCT NCT02536820
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02536820. Non-randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study
Acronym
PNIT
Condition
Diabetes Mellitus, Type 2
Intervention (Behavioral)
psychoneuroimmune therapy
Intervention (Drug)
Conventional treatment
Lead sponsor
Fundación Salutia (class: other)
Collaborator
Coomeva E.P.S (class: not stated)
Collaborator
Sinergia (class: not stated)

Record details

Record id
cardio:ct-nct02536820
Content hash
391e3801091590dea40f30feb997fd8759f9e37a48e4e40af7b42421a896b678